Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-22

Clinical Trial Update: A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants [NA]

View source ↗

Summary

This document reports a clinical trial evaluating Seattle-PAP for respiratory support in premature infants. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Premature Birth | NA | Status: UNKNOWN